CONTRATOS ARTICULO 60 LOSU
Contrato
Experience In The Field of On Potential Indications of Molecules That Inhibit Nlrp3 And Potential Techniques To Use In The Design of Drugs That Inhibit Nlrp3.
Financiador:
GLENMARK PHARMACEUTICALS LIMITED
date_range
Duración do 22 de abril de 2021 ao 22 de abril de 2022
(12 meses)
euro
607,50 EUR
De ámbito Internacional (non UE). Con carácter Privado.
Investigadores/as
Pablo
Pelegrin Vivancos
Responsable